Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Immunomedics, Inc. (IMMU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VIEWS: 0 PAGES: 20

Immunomedics, Inc. (Immunomedics) is a New Jersey-based biopharmaceutical company. The company develops monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. The company developed advanced technologies that create humanized antibodies that can be used either alone in unlabeled form or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create highly targeted agents. Through these technologies, the company built a pipeline of therapeutic product candidates. The company operates in Canada, Europe, Germany and the US.

More Info
									                  Immunomedics, Inc. (IMMU) - Pharmaceuticals & Healthcare - Deals and
                                           Alliances Profile
       Reference Code: GDPH58576D                                                                                                             Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Immunomedics, Inc. (Immunomedics) is a New Jersey-based biopharmaceutical
                                                                                                              Immunomedics, Inc., Pharmaceuticals &
      company. The company develops monoclonal, antibody-based products for the
                                                                                                              Healthcare, Key Facts, 2012
      targeted treatment of cancer, autoimmune and other serious diseases. The
      company developed advanced technologies that create humanized antibodies that                            Web Address                       www.immunomedics.co
      can be used either alone in unlabeled form or conjugated with radioactive isotopes,                                                        m
      chemotherapeutics or toxins, in each case to create highly targeted agents. Through
                                                                                                               Revenue (US$ million)                                    32.73
      these technologies, the company built a pipeline of therapeutic product candidates.
      The company operates in Canada, Europe, Germany and the US.                                              Number of Employees                                       124
                                                                                                               GlobalData

      Financial Deals Landscape
        Immunomedics, Inc., Pharmaceuticals & Healthcare, Deals by                        Immunomedics, Inc., Pharmaceuticals & Healthcare, Deals
        Type, 2007 to YTD 2013                                                            By Year, 2007 to YTD 2013


                                                                                                                                    2
                                                                                                          2

                                                                                           No. of Deals
                                                                                                                 1        1                      1        1
                                                                                                          1


                                                                                                                                          0                         0
                                                                                                          0
                                                                                                               2007      2008    2009    2010   2011     2012   YTD
                                                                                                                                                                2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Immunomedics, Inc., Pharmaceuticals & Healthcare, Deals                          Immunomedics, Inc., Pharmaceuticals & Healthcare, Deals
         By Region, 2007 to YTD 2013                                                      By Therapy Area, 2007 to YTD 2013

                         8                                                                                6          5
                               6                                                                                                4
          No. of Deals




                                                                                                          5
                                                                                           No. of…




                         6                                                                                4
                                                                                                          3                               2
                                        3                                                                 2                                          1          1
                         4
                                                 2         2         2                                    1
                                                                                                          0
                         2
                                                                                                                Immun         Oncolo    Genito Hemato Infectio
                         0                                                                                       ology          gy      Urinary logical   us
                             North    Europe    Asia-    Middle   South                                                                 System Disorde Disease
                             Americ            Pacific    East     and                                                                   And      rs
                               a                          and     Central                                                                 Sex
                                                         Africa   Americ                                                                Hormo
                                                                    a                                                                     nes



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Immunomedics, Inc. - Pharmaceuticals & Healthcare - Deals and                                                                                   Reference Code: GDPH58576D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                      Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Immunomedics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................. 3
       Immunomedics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 .................................................................. 5
       Immunomedics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .............................................................. 6
       Immunomedics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ................................................... 7
       Immunomedics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ............................................................... 8
       Immunomedics, Inc., Pharmaceuticals & Healthcare, Deal Details .................................................................................................... 9
          Licensing Agreements .................................................................................................................................................................... 9
             Immunomedics Amends Licensing Agreement With UCB For Epratuzumab .............................................................................. 9
             Immunomedics Enters Into Licensing Agreement With Alexis Biotech...................................................................................... 10
             Immunomedics Enters Into Licensing Agreement With Nycomed International ........................................................................ 11
          Equity Offering .............................................................................................................................................................................. 13
             Immunomedics Files Shelf Registration Statement For Public Offering Of Shares For $70 Million........................................... 13
             Immunomedics Files Shelf Registration Statement For Public Offering Of $151 Million ........................................................... 14
             Immunomedics Completes Private Placement Of $24 Million ................................................................................................... 16
       Immunomedics, Inc. - Key Competitors ............................................................................................................................................ 17
       Key Employees ................................................................................................................................................................................ 18
       Locations And Subsidiaries .......................
								
To top